Their preclinical studies demonstrated that iC9/CAR.19/IL-15 CB NK cells efficiently killed CD19+ primary leukemia cells and Raji in vitro and significantly prolonged the survival in a xenograft Raji lymphoma murine model [56]. Here, IL15 is linked to leukemia.